Tumor Rupture in a Patient with Recurrent Hepatocellular Carcinoma Following Atezolizumab plus Bevacizumab: A Case Report.
Authors
- Ryoichi Narita
- Shohei Yoshiya (ORCID: https://orcid.org/0000-0003-4642-5058)
- Takaaki Mori (ORCID: https://orcid.org/0000-0001-5301-2265)
- Kentaro Iwaki (ORCID: https://orcid.org/0000-0003-1168-3161)
- Kengo Fukuzawa (ORCID: https://orcid.org/0000-0002-3281-8224)
- Yo‐ichi Yamashita (ORCID: https://orcid.org/0000-0001-8439-6660)
- Kazuhiro Tada (ORCID: https://orcid.org/0000-0002-6611-1059)
- Hajime Takaki
- Shotaro Nakamura (ORCID: https://orcid.org/0000-0001-8166-2599)
- Yasunari Yamada
Institutions
- Oita Red Cross Hospital (JP)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- DOI
- https://doi.org/10.70352/scrj.cr.25-0331
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00